Abstract:Objective To investigate the effect of amoxicillin clavulanate potassium granule combined with Jinzhen oral liquid in the treatment of children with bronchial pneumonia (BP).Methods A total of 80 children with BP admitted to Fuzhou Maternal and Child Health Hospital from January 2021 to January 2023 were randomly divided into 2 groups, with 40 cases in each group. The control group was treated with amoxicillin clavulanate potassium granules. The observation group was treated with amoxicillin clavulanate potassium granules combined with Jinzhen oral liquid. Both groups were treated for 7 days. Symptom resolution time, inflammatory factors and lung function were compared between the two groups.Results The time of fever reduction 〔(2.20±0.49) d 〕, pulmonary rale 〔(4.20±0.59) d 〕, cough 〔(3.70±0.57) d 〕 and wheezing disappearance 〔(3.50±0.57) d 〕 in the observation group were shorter than those in the control group 〔(3.45±0.59) d, (5.88±0.71) d, (5.37±0.69) d, (5.26±0.68) d 〕, respectively (P<0.05); After treatment, the serum levels of tumor necrosis factor α (TNF-α), hypersensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6), respiratory rate (RR) and respiratory time ratio (Ti/Te) in two groups were lower than those of before treatment, and those in the observation group were lower than those in the control group, respectively; and the tidal volume (VT) in two groups were higher than those of before treatment, and those in the observation group were higher than those in the control group, respectively (P<0.05).Conclusion Amoxicillin clavulanate potassium granule combined with Jinzhen oral liquid can regulate inflammatory factors and improve lung function and clinical symptoms in BP children.